Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · regulatory

Trump touts deals with nine more pharmaceutical companies

1 September 2026 · By · Wire by Fusion42

Published

1 September 2026

Topic

regulatory

◆ Sectors

Healthtech Infrastructure

◆ Geography

United States

◆ Source

Read at upi.com →

◆ Verified

Fusion42 · 1 September 2026 · Fusion42 review

President Donald Trump's administration has secured deals with nine additional pharmaceutical companies to lower drug prices for state Medicaid programs by tying U.S. prices to those charged in other wealthy nations, increasing the number of participating companies to 26 representing 90% of the domestic pharmaceutical market.

This Wire brief tracks EternaFusion, and It sits within Fusion42's coverage of Healthtech Infrastructure, and 2 sources have reported it between 31 Aug 2026 and 1 Sep 2026.

◆ ◆ The Wire takeaway

Your drugs now face pressure to match prices in richer countries, opening state Medicaid deals and market access routes tied to compliance. The unknown deal details mean you must engage closely with providers to stay competitive in this shifting pricing environment.

◆ Mentioned in this story

◆ Coverage

2 sources · first reported 31 Aug 2026 · latest 1 Sep 2026

◆ Related on Wire

◆ Topics

Healthtech Infrastructuredrug-pricespharma-dealsmedicaidprice-controlsus-policy